Your browser is no longer supported. Please, upgrade your browser.
Palisade Bio, Inc.
Index- P/E- EPS (ttm)-4.05 Insider Own0.32% Shs Outstand2.89M Perf Week8.73%
Market Cap32.30M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float- Perf Month-21.71%
Income-11.00M PEG- EPS next Q- Inst Own5.80% Short Float- Perf Quarter-52.76%
Sales- P/S- EPS this Y69.10% Inst Trans12.04% Short Ratio0.11 Perf Half Y-1.83%
Book/sh2.68 P/B1.53 EPS next Y- ROA-81.00% Target Price- Perf Year-16.46%
Cash/sh0.84 P/C4.89 EPS next 5Y- ROE-91.80% 52W Range3.00 - 16.02 Perf YTD-22.16%
Dividend- P/FCF- EPS past 5Y54.40% ROI- 52W High-74.34% Beta1.78
Dividend %- Quick Ratio8.60 Sales past 5Y- Gross Margin- 52W Low36.97% ATR0.46
Employees5 Current Ratio8.60 Sales Q/Q- Oper. Margin- RSI (14)40.76 Volatility8.39% 11.13%
OptionableNo Debt/Eq0.00 EPS Q/Q85.80% Profit Margin- Rel Volume0.44 Prev Close3.93
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.34M Price4.11
Recom- SMA206.59% SMA50-38.28% SMA200-32.82% Volume587,896 Change4.58%
Jun-07-21 05:06PM  
May-13-21 07:00AM  
May-07-21 09:07AM  
May-04-21 08:00AM  
Leading BioSciences, Inc. develops therapeutics to improve human health through therapeutic protection of the gastrointestinal mucosal barrier. The company was founded in 2005 and is based in Carlsbad, California.